Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-005463

Options or other derivatives

  • Chief Scientific Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Russell Alan J · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +120,000 120,000 D
Loading xslF345X03/primarydocument.xml…